Literature DB >> 3426294

Oral methotrexate in the treatment of rheumatoid arthritis: allergic agranulocytosis?

M Brumage, L Trümper, M Seitz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3426294      PMCID： PMC1003409          DOI： 10.1136/ard.46.11.875-b

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

Review 1.  Systemic complications of commonly used dermatologic drugs.

Authors:  G G Gruber; J P Callen
Journal:  Cutis       Date:  1978-06

2.  Acute bone marrow suppression following one day oral administration of methotrexate.

Authors:  M G Pierik
Journal:  R I Med J       Date:  1974-08

Review 3.  Methotrexate guidelines--revised.

Authors:  H H Roenigk; R Auerbach; H I Maibach; G D Weinstein
Journal:  J Am Acad Dermatol       Date:  1982-02       Impact factor: 11.527

Review 4.  Methotrexate.

Authors:  G D Weinstein
Journal:  Ann Intern Med       Date:  1977-02       Impact factor: 25.391

5.  Methotrexate-induced immune haemolytic anaemia.

Authors:  P V Woolley; R A Sacher; V M Priego; M S Schanfield; E M Bonnem
Journal:  Br J Haematol       Date:  1983-08       Impact factor: 6.998

6.  Pancytopenia associated with low dose pulse methotrexate in the treatment of rheumatoid arthritis.

Authors:  S K MacKinnon; G Starkebaum; R F Willkens
Journal:  Semin Arthritis Rheum       Date:  1985-11       Impact factor: 5.532
  6 in total
  1 in total

1.  Drug-induced agranulocytosis in the Berlin case-control surveillance study.

Authors:  Matthias Huber; Frank Andersohn; Elisabeth Bronder; Andreas Klimpel; Michael Thomae; Christine Konzen; Oliver Meyer; Abdulgabar Salama; Hubert Schrezenmeier; Martin Hildebrandt; Ernst Späth-Schwalbe; Andreas Grüneisen; Reinhold Kreutz; Edeltraut Garbe
Journal:  Eur J Clin Pharmacol       Date:  2013-12-03       Impact factor: 2.953
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.